thymoquinone has been researched along with paclitaxel in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Horrocks, P; Johnson-Ajinwo, OR; Li, WW; Mbye, H; Richardson, A; Ullah, I | 1 |
| Banik, P; Kumar, BN; Mandal, M; Parida, S; Rajput, S | 1 |
| Aksu, H; Çakır, M; Canatan, H; İskender, B; İzgi, K; Kurt, B; Şakalar, Ç; Sezen, S; Turan, A | 1 |
| Ajabnoor, GM; Al-Abd, AM; Alamoudi, AA; Bashmail, HA; Hegazy, GA; Noorwali, A | 1 |
| Abdolmaleki, A; Jalili, C; Moradi Maryamneghari, S; Shokri-Asl, V | 1 |
| Hamid, SBS; Kaus, NHM; Noor, NS; Szewczuk, MR | 1 |
| Chen, J; Chen, Y; Liu, X; Xing, H; Yan, M; You, M; Zhang, J; Zhang, S; Zhu, J | 1 |
8 other study(ies) available for thymoquinone and paclitaxel
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
The synthesis and evaluation of thymoquinone analogues as anti-ovarian cancer and antimalarial agents.
Topics: Antimalarials; Antineoplastic Agents; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Malaria, Falciparum; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2018 |
Thymoquinone restores radiation-induced TGF-β expression and abrogates EMT in chemoradiotherapy of breast cancer cells.
Topics: Apoptosis; Benzoquinones; Breast Neoplasms; Cell Line, Tumor; Cell Transdifferentiation; Epithelial-Mesenchymal Transition; Female; Humans; Paclitaxel; Radiation; Radiotherapy; Transforming Growth Factor beta | 2015 |
The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Benzoquinones; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Screening Assays, Antitumor; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Mammary Neoplasms, Experimental; Mice, Inbred BALB C; Neoplasm Transplantation; Paclitaxel; Triple Negative Breast Neoplasms; Tumor Burden | 2016 |
Thymoquinone Enhances Paclitaxel Anti-Breast Cancer Activity via Inhibiting Tumor-Associated Stem Cells Despite Apparent Mathematical Antagonism.
Topics: Benzoquinones; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; MCF-7 Cells; Neoplastic Stem Cells; Nuclear Proteins; Paclitaxel; Snail Family Transcription Factors; Twist-Related Protein 1 | 2020 |
Genetic, biochemical and histopathological evaluations of thymoquinone on male reproduction system damaged by paclitaxel in Wistar rats.
Topics: Animals; Antioxidants; Benzoquinones; Male; Molecular Biology; Oxidative Stress; Paclitaxel; Rats; Rats, Wistar; Reproduction; Sperm Motility; Spermatozoa; Testis; Testosterone | 2021 |
Formulation, Characterization and Cytotoxicity Effects of Novel Thymoquinone-PLGA-PF68 Nanoparticles.
Topics: Antineoplastic Agents, Phytogenic; Benzoquinones; Breast Neoplasms; Drug Compounding; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Nanoparticles; Paclitaxel; Poloxamer; Polylactic Acid-Polyglycolic Acid Copolymer | 2021 |
Thymoquinone Alleviates Paclitaxel-Induced Peripheral Neuropathy through Regulation of the TLR4-MyD88 Inflammatory Pathway.
Topics: Animals; Mice; Molecular Docking Simulation; Myeloid Differentiation Factor 88; Neuroprotective Agents; NF-kappa B; Paclitaxel; Peripheral Nervous System Diseases; Toll-Like Receptor 4 | 2023 |